I liked both Versum (VSM) and Entegris (ENTG)
in the fall of 2018, Entegris a little moreso, on the idea that the
market was overreacting to the correction cycle in semiconductors and
semiconductor equipment and that underlying chip production (a key driver
for Versum) was unlikely to be impacted as much as seemed to be
reflected in the prices. When Versum and Entegris announced their intent
to merge in late January, I thought it made a lot of sense and would
create a stronger new company, led by management team (Entegris) with a
lot of experience in M&A integration.
Now Merck KGaA (OTCPK:MKKGY) has pushed itself into the conversation, making
an unsolicited all-cash offer that is well above the upfront value
offered by the Entegris deal. Although I can see why some shareholders
may prefer a stock-for-stock bid and I believe there are some regulatory
risks to the Merck KGaA offer, it’s hard to argue with an all-cash
offer that is well above what Versum shareholders were otherwise
expecting.
Click here for more:
Merck KGaA Crashes Into The Versum-Entegris Tie-Up
No comments:
Post a Comment